- 3.10.2026
- Featured
- Press Releases
VETS Co-Founder & CEO Amber Capone Named to Inc.'s 2026 Female Founders 500 List for Second Consecutive Year
Amber Capone, co-founder and CEO of VETS, has been named to Inc.’s 2026 Female Founders 500 List for the second consecutive year, recognizing her leadership in advancing research, policy reform, and expanded access to psychedelic-assisted therapies for veterans.
- 9.24.2025
- Featured
- Press Releases
- Video
Press Release: Critically Acclaimed Documentary 'In Waves and War' Releases Trailer and Key Art Ahead of Los Angeles Theatrical Release and Nov. 3 Streaming Premiere on Netflix
Hailed by critics as “powerful”, “infused with hope” and “storytelling filled with compassion”, the film has spent the past year building awareness around veterans’ issues, mental health, PTSD and alternative treatments.
- 9.8.2025
- Featured
- Press Releases
Veteran Advocacy Leaders Launch VALOR Coalition to Combat Veteran Suicide and Advance Mental Health Policy
VETS has joined forces with the Navy SEAL Foundation, Green Beret Foundation, and Wounded Warrior Project to launch the VALOR Coalition—a united effort to advance mental health policy, expand access to psychedelic-assisted therapies, and end the veteran suicide crisis.
- 8.13.2025
- Featured
- Press Releases
Press Release: Veterans Exploring Treatment Solutions (VETS) Announces Sponsors for 4th Annual Torchbearer Ball
Black-tie gala returns November 15, 2025, at the Hotel del Coronado—uniting changemakers, honoring documentary filmmakers, and raising critical funds for life-changing therapies for veterans Gala Celebrates Netflix Documentary In Waves and War - Premiering on November 3, 2025
- 6.13.2025
- Featured
- Press Releases
Press Release: Veterans Exploring Treatment Solutions (VETS) Applauds Texas on Passing the Largest Publicly Funded Psychedelic Research Investment in U.S. History
VETS celebrates the passage of the Texas Ibogaine Initiative—landmark legislation that allocates $100 million in public and private funding to study ibogaine-assisted therapy for PTSD, addiction, and TBI. This historic investment, driven in large part by VETS’ advocacy, positions Texas as a national leader in psychedelic research and veteran mental health care.